Skip to content
10-Q

Quarterly Report

WEST PHARMACEUTICAL SERVICES INC WST

0000105770-26-000049

← back to feed
Filed
Apr 23, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 20, 2026 70.65M sh
Shares Diluted Q1 2026 · Mar 31, 2026 72.4M sh
Shares Diluted Q1 2026 · Mar 31, 2025 73M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $297.6M
Stock Repurchased Q1 2026 · Mar 31, 2025 $133.5M
Dividends Paid Q1 2026 · Mar 31, 2026 $15.8M
Dividends Paid Q1 2026 · Mar 31, 2025 $15.2M
Capex Q1 2026 · Mar 31, 2026 $42.7M
Capex Q1 2026 · Mar 31, 2025 $71.3M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $89.9M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $129.4M
Long Term Debt Q1 2026 · Mar 31, 2026 $202.8M
Long Term Debt Q1 2026 · Dec 31, 2025 $202.8M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $521.4M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $791.3M
Stockholders Equity Q1 2026 · Mar 31, 2026 $2.99B
Stockholders Equity Q1 2026 · Dec 31, 2025 $3.18B
Stockholders Equity Q1 2026 · Mar 31, 2025 $2.68B
Stockholders Equity Q1 2026 · Dec 31, 2024 $2.68B
Current Liabilities Q1 2026 · Mar 31, 2026 $674M
Current Liabilities Q1 2026 · Dec 31, 2025 $654.9M
Total Liabilities Q1 2026 · Mar 31, 2026 $1.12B
Total Liabilities Q1 2026 · Dec 31, 2025 $1.09B
Current Assets Q1 2026 · Mar 31, 2026 $1.83B
Current Assets Q1 2026 · Dec 31, 2025 $1.98B
Total Assets Q1 2026 · Mar 31, 2026 $4.11B
Total Assets Q1 2026 · Dec 31, 2025 $4.27B
Eps Diluted Q1 2026 · Mar 31, 2026 $1.92
Eps Diluted Q1 2026 · Mar 31, 2025 $1.23
Eps Basic Q1 2026 · Mar 31, 2026 $1.93
Eps Basic Q1 2026 · Mar 31, 2025 $1.24
Sga Expense Q1 2026 · Mar 31, 2026 $99.5M
Sga Expense Q1 2026 · Mar 31, 2025 $88M
Rd Expense Q1 2026 · Mar 31, 2026 $15.8M
Rd Expense Q1 2026 · Mar 31, 2025 $16.3M
Net Income Q1 2026 · Mar 31, 2026 $138.8M
Net Income Q1 2026 · Mar 31, 2025 $89.8M
Operating Income Q1 2026 · Mar 31, 2026 $177.1M
Operating Income Q1 2026 · Mar 31, 2025 $107M
Gross Profit Q1 2026 · Mar 31, 2026 $296.4M
Gross Profit Q1 2026 · Mar 31, 2025 $231.9M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $548.5M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $466.1M
Revenue Q1 2026 · Mar 31, 2026 $844.9M
Revenue Q1 2026 · Mar 31, 2025 $698M